FDA-EMA Pilot Could Further Push Global Generic Harmonization, But Will Sponsors Use It?

The FDA-EMA parallel scientific advice pilot for complex generics is an expansion of the existing program for new drugs and biologics. • Source: Alamy

More from Review Pathways

More from Pathways & Standards